COR vs IQV · P/E 21, rev $321.33B vs P/E 23, rev $15.40B
Cencora Inc. (COR) versus IQVIA Holdings Inc (IQV) — a side-by-side from cached financials, not a winner call.
Cencora Inc. (COR) is a medical distribution company listed on NYSE.
IQVIA Holdings Inc (IQV) is a diagnostics & research company listed on US.
Latest reported COR revenue for 2025-09-30 was $321.33B. Net income was $1.57B. Revenue was up 9.3% from 2024-09-30 to 2025-09-30. COR currently screens at market cap $53.91B and trailing P/E 21.2.
Latest reported IQV revenue for 2024-12-31 was $15.40B. Net income was $1.37B. Revenue was up 2.8% from 2023-12-31 to 2024-12-31. IQV currently screens at market cap $30.62B and trailing P/E 22.8.
COR currently screens at market cap $53.91B and trailing P/E 21.2. IQV currently screens at market cap $30.62B and trailing P/E 22.8.
Not investment advice. Open the COR and IQV stock pages for the full models.
Not investment advice.